ArticleCell communication and signaling : CCS2026
RhoB supports rubella infection and impairs endothelial barrier integrity through downstream ROCK signaling.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuring infection, alterations of the endothelium’s barrier function are multifaceted and virus-specific. Rubella virus (RuV) infection during pregnancy damages the endothelium in the placental and fetal vasculature, thereby contributing to the development of congenital rubella syndrome. However, the extent and mechanisms behind RuV-induced endothelial barrier disruption have not been previously documented.
methodsTo investigate if RuV directly impairs endothelial barrier integrity, we infected primary human umbilical vein endothelial cells and analyzed the barrier integrity using Electrical Cell-Substrate Impedance Sensing (ECIS). Furthermore, we applied fluorescence microscopy to analyze RuV-induced changes in cell morphology, the actin cytoskeleton, and cell–cell junctions. To dissect the molecular mechanisms behind the observed alterations induced by RuV infection in endothelial cells, we determined levels of RhoA and RhoB GTPases, followed by depletion of both proteins using siRNA transfection and application of pharmacological inhibitors of the Rho/ROCK signaling axis.
resultsRubella virus infection in endothelial cells induced a comparatively low level of cytopathogenicity, accompanied by an elongated morphology. Most notably, a reduction in endothelial barrier integrity occurred at later time points of infection, as measured by ECIS. While the overall expression levels of junctional proteins appeared unaffected, membrane localization of zonula occludens-1 (ZO-1) was significantly reduced. This was accompanied by a marked increase in actin stress fibers and enhanced RhoB GTPase levels. The siRNA-mediated downregulation combined with time-dependent inhibitor application confirmed a contributory role for RhoB to RuV infection at early post-entry steps. The elongated morphology of infected endothelial cells was associated with the chemokine CCL5. Notably, cell elongation induced by treatment with supernatant from infected cells was insufficient to impair the barrier integrity in the absence of productive RuV replication. In comparison, depletion of RhoB expression or ROCK inhibitor application revealed the involvement of the RhoB/ROCK signaling axis in the impairment of barrier integrity and induction of stress fibers by RuV infection. Additionally, altered localization of ZO-1 was restored after application of ROCK inhibitor Y-27632 to uninfected control levels.
conclusionsCollectively, our data highlight the involvement of Rho GTPase–ROCK signaling in alterations of endothelial cell actin dynamics and barrier integrity in rubella virus pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.